lansoprazole has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 4 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drago, F | 1 |
| Javor, S | 1 |
| Ciccarese, G | 1 |
| Cozzani, E | 1 |
| Parodi, A | 1 |
| Panting, KJ | 1 |
| Pinto, M | 1 |
| Ellison, J | 1 |
| Bracke, A | 1 |
| Nijsten, T | 1 |
| Vandermaesen, J | 1 |
| Meuleman, L | 1 |
| Lambert, J | 1 |
| Dam, C | 1 |
| Bygum, A | 1 |
4 other studies available for lansoprazole and Lupus Erythematosus, Cutaneous, Subacute
| Article | Year |
|---|---|
Subacute cutaneous lupus erythematosus induced by lansoprazole.
Topics: Female; Humans; Lansoprazole; Lupus Erythematosus, Cutaneous; Middle Aged | 2015 |
Lansoprazole-induced subacute cutaneous lupus erythematosus.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Enzyme Inhibitors; Female; Gastroenteritis; Humans; Lansopr | 2009 |
Lansoprazole-induced subacute cutaneous lupus erythematosus: two cases.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Diagnosis, Differential; Female; Humans; Lansoprazole | 2005 |
Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Autoantibodies; Duodenal Ulcer; Esophagitis; Female; Humans | 2008 |